176 related articles for article (PubMed ID: 26871237)
1. Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.
Sanford JC; Wang X; Shi J; Barrie ES; Wang D; Zhu HJ; Sadee W
Pharmacogenet Genomics; 2016 May; 26(5):197-207. PubMed ID: 26871237
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.
Wang X; Rida N; Shi J; Wu AH; Bleske BE; Zhu HJ
Drug Metab Dispos; 2017 Nov; 45(11):1149-1155. PubMed ID: 28838926
[TBL] [Abstract][Full Text] [Related]
3. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
Wang X; Wang G; Shi J; Aa J; Comas R; Liang Y; Zhu HJ
Pharmacogenomics J; 2016 Jun; 16(3):220-30. PubMed ID: 26076923
[TBL] [Abstract][Full Text] [Related]
4. Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.
Neuvonen M; Tarkiainen EK; Tornio A; Hirvensalo P; Tapaninen T; Paile-Hyvärinen M; Itkonen MK; Holmberg MT; Kärjä V; Männistö VT; Neuvonen PJ; Pihlajamäki J; Backman JT; Niemi M
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):341-345. PubMed ID: 28990360
[TBL] [Abstract][Full Text] [Related]
5. CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.
Zhu HJ; Langaee TY; Gong Y; Wang X; Pepine CJ; Cooper-DeHoff RM; Johnson JA; Markowitz JS
Eur J Clin Pharmacol; 2016 Jun; 72(6):681-7. PubMed ID: 26915813
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Structural Variants of the
Ikonnikova A; Kazakov R; Rodina T; Dmitriev A; Melnikov E; Zasedatelev A; Nasedkina T
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553492
[TBL] [Abstract][Full Text] [Related]
7. Identification of regulatory variants of carboxylesterase 1 (CES1): A proof-of-concept study for the application of the Allele-Specific Protein Expression (ASPE) assay in identifying cis-acting regulatory genetic polymorphisms.
Her L; Shi J; Wang X; He B; Smith LS; Jiang H; Zhu HJ
Proteomics; 2023 Jan; 23(1):e2200176. PubMed ID: 36413357
[TBL] [Abstract][Full Text] [Related]
8. Functional Study of Carboxylesterase 1 Protein Isoforms.
Wang X; Shi J; Zhu HJ
Proteomics; 2019 Feb; 19(4):e1800288. PubMed ID: 30520264
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis.
Lian J; Bahitham W; Panigrahi R; Nelson R; Li L; Watts R; Thiesen A; Lemieux MJ; Lehner R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):688-699. PubMed ID: 29631096
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
[TBL] [Abstract][Full Text] [Related]
11. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.
Shi J; Wang X; Eyler RF; Liang Y; Liu L; Mueller BA; Zhu HJ
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):555-561. PubMed ID: 27228223
[TBL] [Abstract][Full Text] [Related]
12. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
Zhu HJ; Wang X; Gawronski BE; Brinda BJ; Angiolillo DJ; Markowitz JS
J Pharmacol Exp Ther; 2013 Mar; 344(3):665-72. PubMed ID: 23275066
[TBL] [Abstract][Full Text] [Related]
13. The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.
Stage C; Jürgens G; Guski LS; Thomsen R; Bjerre D; Ferrero-Miliani L; Lyauk YK; Rasmussen HB; Dalhoff K;
Br J Clin Pharmacol; 2017 Jul; 83(7):1506-1514. PubMed ID: 28087982
[TBL] [Abstract][Full Text] [Related]
14. Carboxylesterase 1A2 encoding gene with increased transcription and potential rapid drug metabolism in Asian populations.
Rasmussen HB; Madsen MB; Lyauk YK; Hansen PR; Hughes T;
Drug Metab Pers Ther; 2017 Sep; 32(3):163-168. PubMed ID: 28803225
[TBL] [Abstract][Full Text] [Related]
15. Carboxylesterase 1 genes: systematic review and evaluation of existing genotyping procedures.
Rasmussen HB; Madsen MB;
Drug Metab Pers Ther; 2018 Mar; 33(1):3-14. PubMed ID: 29427553
[TBL] [Abstract][Full Text] [Related]
16. Examination of the carboxylesterase phenotype in human liver.
Ross MK; Borazjani A; Wang R; Crow JA; Xie S
Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
[TBL] [Abstract][Full Text] [Related]
17. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.
Shi J; Wang X; Nguyen J; Wu AH; Bleske BE; Zhu HJ
Drug Metab Dispos; 2016 Apr; 44(4):554-9. PubMed ID: 26817948
[TBL] [Abstract][Full Text] [Related]
18. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
Her L; Zhu HJ
Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
[TBL] [Abstract][Full Text] [Related]
19. The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios.
Stage C; Dalhoff K; Rasmussen HB; Schow Guski L; Thomsen R; Bjerre D; Ferrero-Miliani L; Busk Madsen M; Jürgens G
Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):54-61. PubMed ID: 30801959
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Regulation of Carboxylesterase 1 in Human Liver: Role of the Nuclear Receptor Subfamily 1 Group H Member 3 and Its Splice Isoforms.
Collins JM; Lu R; Wang X; Zhu HJ; Wang D
Drug Metab Dispos; 2022 Jan; 50(1):43-48. PubMed ID: 34697082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
